Stirlingshire Investments, Inc.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1829271
NEW YORK, NY
Position in UTHR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$494,690
+$186,341 QoQ
Shares Held
913
+75.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#573
of 870 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Stirlingshire Investments, Inc. holds $643,032 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (76.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
913 | $494,690 | |
| 2 | EBS |
Emergent BioSolutions Inc.
|
17,702 | $148,342 |
All Filings in UTHR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $494,690 | 913 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $308,349 | 520 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $235,829 | 484 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||